Pulmonary disposition of vancomycin in critically ill patients

Eur J Clin Microbiol Infect Dis. 1997 May;16(5):385-8. doi: 10.1007/BF01726369.

Abstract

Vancomycin penetration in epithelium lining fluid was studied in ten mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia 24 hours after the onset of treatment. Vancomycin was given intravenously at a daily dose of 30 mg/kg. Vancomycin levels were detectable in four patients (range, 1-2.77 micrograms/ml). Concordance between high plasma concentrations (> 20 micrograms/ml) and detectable vancomycin levels in epithelium lining fluid was noted. These results suggest that the pulmonary disposition of vancomycin remains low for most patients 24 h after the onset of treatment compared with the minimum inhibitory concentrations for most gram-positive organisms. One therapeutic goal of vancomycin treatment could be to obtain through plasma levels of 20 micrograms/ml. Further studies are required to determine the clinical relevance of these observations.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacokinetics*
  • Anti-Bacterial Agents / therapeutic use
  • Bronchoalveolar Lavage Fluid / chemistry*
  • Bronchoscopy
  • Critical Illness
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Methicillin Resistance*
  • Middle Aged
  • Pneumonia, Bacterial / diagnosis
  • Pneumonia, Bacterial / drug therapy*
  • Pneumonia, Bacterial / physiopathology
  • Prospective Studies
  • Respiration, Artificial
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / physiopathology
  • Treatment Outcome
  • Vancomycin / pharmacokinetics*
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Vancomycin